Sector Novavax, Inc.

Aandelen

NVAX

US6700024010

Biotechnologie & Medisch Onderzoek

Geschatte realtime Cboe BZX 21:28:37 22-04-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
8,445 USD -0,53% Intraday-grafiek van Novavax, Inc. -2,59% +25,97%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
-0,53%-2,59%-12,91%-13,18%+25,97%+35,44%+4,76%-95,92%-92,44% 1,38 mld.
-0,55%-4,80%+8,73%-8,47%-5,50%-7,47%-12,17%-9,83%+216,24% 45,74 mld.
-0,61%-3,22%+12,71%-8,61%+1,92%+22,50%+20,30%-0,46%+935,24% 34,63 mld.
-4,45%-6,63%+47,40%+19,88%+78,82%+286,41%+518,45%+252,29% - 31,32 mld.
-0,32%-1,45%+5,13%-26,57%-22,13%+22,22%-13,53%-22,31%+150,61% 29,49 mld.
+0,49%+2,46%+0,99%0,00%+12,71%+34,79%+32,44%-18,65%+170,26% 28,78 mld.
-4,36%-4,72%+5,61%+0,72%+8,00%+44,72%+188,71%+74,67%+1.214,50% 14,85 mld.
-1,73%-2,14%+11,06%-16,30%-9,65%+79,77%+170,98%+170,65% - 14,7 mld.
-9,69%-9,79%+3,09%-12,22%+0,38%+26,93%+2,69%-27,54%+98,13% 14,34 mld.
+4,14%-2,77%+14,95%-5,80%+38,02%+3.724,38%+4.009,60% - - 14,04 mld.
-0,08%-2,45%+5,86%-8,38%-5,27%+158,15%+109,80%+76,50%+72,51% 12,35 mld.
+0,13%-2,00%+12,49%-19,13%-6,38%+27,87% - - - 9,88 mld.
-1,27%-0,80%+14,66%+10,79%+14,41%+837,23%+2.020,85%-25,16% - 9,49 mld.
-1,98%-0,21%+12,25%-16,20%-0,75%+18,93%-30,59%-44,90%+146,23% 9,34 mld.
+1,17%-4,30%-2,03%-4,66%-17,65%+1.746,37%+534,76%+350,68%+854,28% 9,12 mld.
+0,14%+1,36%+15,83%-18,31%-8,26%+71,21%-10,21%-44,15%+125,97% 9,03 mld.
+0,47%-0,92%+15,03%-38,19%-36,65%-15,62%-44,09%-45,68%+55,13% 8,8 mld.
-0,36%-4,06%+1,16%-26,36%-15,60%-10,36%-21,39%-30,23%+44,45% 8,29 mld.
+0,14%-.--%-.--%-.--%-.--%+53,79%+163,93%+36,42%+605,12% 8,38 mld.
+1,20%-3,00%+15,92%-1,39%+7,07%+34,99%-10,44%-55,90% - 7,46 mld.
Gemiddelde -0,95%-0,48%+9,40%-9,62%+2,97%+359,61%+401,83%+30,03%+328,30% 16,07 mld.
Gewogen gemiddelde per kap. -1,15%-0,64%+11,89%-7,67%+5,96%+289,50%+334,96%+39,17%+375,43%
Biotechnologie & Medisch Onderzoek - Andere
  1. Beurs
  2. Aandelen
  3. Koers NVAX
  4. Sector Novavax, Inc.